PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30810635-9	2019	Treatment with 1 mg/kg gliclazide reduced myeloperoxidase activity, malondialdehyde, IL-1beta, and TNF-alpha levels (p<=0.05), and resulted in weak staining for COX-2, cathepsin k, MMP-2, RANK, RANKL, SOD-1, GPx-1,MIF and PI3k.	Gliclazide	23-33	glutathione peroxidase 1	Rattus norvegicus	211-216